It started with a chat over coffee about their work, which focuses on different aspects of the cancer continuum. One researcher looks at the rate of ...
DUBAI, United Arab Emirates;February 2025 - Throat cancer is one of the fastest-growing cancers, and it is often linked to ...
Valentine’s Day is traditionally a time for chocolates, flowers, and romantic dinners. But what if this year, you and your ...
This is an educational message sponsored by MSD Philippines. Valentine’s Day is traditionally a time for chocolates, flowers, and romantic dinners. But what if this year, you and your partner focused ...
Gut bacteria are to blame for the failure of immune checkpoint therapy for ovarian cancer, new research reveals.
A research team has developed a multi-medium approach (MMA) to identify reproducible volatile organic compounds (VOCs) in ...
Chronic pain is a worldwide epidemic that disproportionately affects women. These surgeons have found innovative solutions - ...
Upon Opdualag’s approval in 2022 as a first-in-class cancer immunotherapy, Bristol Myers Squibb was anxious to explore its potential in a variety of indications. | Bristol Myers Squibb is striking out ...
Several important steps should be taken and/or considered after the identification of an oral cavity lesion: Perform a ...
A new FDA approval stands to give Daiichi Sankyo’s Turalio some company in a rare tumor type. | The new FDA approval gives ...
NEW YORK - OS Therapies, Inc. (NYSE-A: OSTX), a small-cap biotech firm with a market capitalization of $42 million focusing on cancer treatment solutions, has announced the completion of its Phase 2b ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback